Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: B02BD13Orphan Medicine

Coagadex(human coagulation factor X)

Factor X Deficiency

Marketing Authorisation Holder: Kedrion S.p.A.

EMA Authorisation: 16/03/2016

INN: human coagulation factor X

Indication

Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency. Coagadex is indicated in all age groups.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Coagadex — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.